BioRem Inc.
BRM.V · TSXV
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | CA$0 | CA$0 | CA$0 | CA$0 |
| % Growth | 19.3% | 99.4% | -49.2% | – |
| Cost of Goods Sold | CA$0 | CA$0 | CA$0 | CA$0 |
| Gross Profit | CA$0 | CA$0 | CA$0 | CA$0 |
| % Margin | 28.1% | 27% | 23.5% | 17.1% |
| R&D Expenses | CA$0 | CA$0 | CA$0 | CA$0 |
| G&A Expenses | CA$0 | CA$0 | CA$0 | CA$0 |
| SG&A Expenses | CA$0 | CA$0 | CA$0 | CA$0 |
| Sales & Mktg Exp. | CA$0 | CA$0 | CA$0 | CA$0 |
| Other Operating Expenses | -CA$0 | CA$0 | -CA$0 | CA$0 |
| Operating Expenses | CA$0 | CA$0 | CA$0 | CA$0 |
| Operating Income | CA$0 | CA$0 | CA$0 | CA$0 |
| % Margin | 14.3% | 11.2% | 2% | 3.1% |
| Other Income/Exp. Net | -CA$0 | -CA$0 | -CA$0 | -CA$0 |
| Pre-Tax Income | CA$0 | CA$0 | CA$0 | CA$0 |
| Tax Expense | CA$0 | CA$0 | CA$0 | CA$0 |
| Net Income | CA$0 | CA$0 | CA$0 | CA$0 |
| % Margin | 10.3% | 7.9% | 0.8% | 1.8% |
| EPS | 0.072 | 0.047 | 0.002 | 0.011 |
| % Growth | 54.8% | 2,225% | -81.1% | – |
| EPS Diluted | 0.062 | 0.04 | 0.002 | -0.023 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | CA$0 | CA$0 | CA$0 | CA$0 |
| Interest Expense | CA$0 | CA$0 | CA$0 | CA$0 |
| Depreciation & Amortization | CA$0 | CA$0 | CA$0 | CA$0 |
| EBITDA | CA$0 | CA$0 | CA$0 | CA$0 |
| % Margin | 15.5% | 12.3% | 4.8% | 4.6% |